ERBB2 and neoplasm: Higher SUVmax, SUVpeak, TLR, and MTV levels at baseline PET/CT were significantly associated with poor clinicopathologic prognostic factors such as large tumor size, higher pathologic prognostic stage, higher tumor grade, negative hormonal receptor, positive HER2 status, and higher Ki-67, all of which are in line with previous reports [21].